Join Dr. Matthew Oberley as he highlights three powerful applications of whole exome and transcriptome sequencing that outperform limited panels. From Caris GPSai™ - an GPSai, an AI tool for identifying tumor origin - to improved accuracy in tumor mutational burden (TMB) measurement, and new COSMIC signatures for UV and tobacco exposure, these examples showcase the value of using all of the genes. Learn how whole exome and transcriptome data can sharpen diagnoses, avoid treatment missteps, and unlock deeper clinical insight to guide better outcomes across the oncology landscape.
